Oncopeptides AB Market Cap

Oncopeptides AB has a market cap or net worth of 408.85 million as of May 6, 2025. Its market cap has decreased by -9.30% in one year.

Market Cap

408.85M

Enterprise Value

372.03M

Revenue

31.65M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.89

Market Cap Chart

Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 408.85M, a decrease of -75.51%. That is a compound annual growth rate of -15.76%.

Market Cap History

Date	Market Cap	% Change
May 5, 2025	408.85M	22.11%
Dec 30, 2024	334.83M	-53.79%
Dec 29, 2023	724.64M	-36.76%
Dec 30, 2022	1.15B	81.18%
Dec 30, 2021	632.45M	-94.51%
Dec 30, 2020	11.53B	63.96%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Swedish Orphan Biovitrum AB	102.97B
Sectra AB	58.26B
Getinge AB	50.87B
Camurus AB	37.06B
Medicover AB	35.88B
AddLife AB	23.45B
Vitrolife AB	20.95B
Bonesupport Holding AB	20.81B

Market Cap Rankings